{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:22:30Z","timestamp":1791516150206,"version":"4.3.4"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.clim.2020.108450","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T02:25:23Z","timestamp":1588127123000},"page":"108450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":253,"special_numbering":"C","title":["The first case of COVID-19 treated with the complement C3 inhibitor AMY-101"],"prefix":"10.1016","volume":"215","author":[{"given":"Sara","family":"Mastaglio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio M.","family":"Risitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piera","family":"Angelillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despina","family":"Yancopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios C.","family":"Mastellos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Huber-Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Piemontese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Assanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Garlanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Lambris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Ciceri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2020.108450_bb0005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.clim.2015.08.009","article-title":"Applying complement therapeutics to rare diseases","volume":"161","author":"Reis","year":"2015","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2020.108450_bb0010","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01753-18","article-title":"Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis","volume":"9","author":"Gralinski","year":"2018","journal-title":"MBio"},{"key":"10.1016\/j.clim.2020.108450_bb0015","first-page":"1","article-title":"Complement as a target in COVID-19?","volume":"2020","author":"Risitano","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2020.108450_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41426-018-0063-8","article-title":"Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV article","volume":"7","author":"Jiang","year":"2018","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.clim.2020.108450_bb0025","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJMra1608077","article-title":"Acute respiratory distress syndrome","volume":"377","author":"Thompson","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2020.108450_bb0030","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.120.047419","article-title":"Will complement inhibition be the new target in treating COVID-19 related systemic thrombosis?","author":"Campbell","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.clim.2020.108450_bb0035","article-title":"Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis","author":"Ciceri","year":"2020","journal-title":"Crit. Care Resusc."},{"key":"10.1016\/j.clim.2020.108450_bb0040","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/eci.12419","article-title":"Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention","volume":"45","author":"Mastellos","year":"2015","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.clim.2020.108450_bb0045","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clim.2016.08.017","article-title":"Compstatin Cp40 blocks hematin-mediated deposition of C3b fragments on erythrocytes: implications for treatment of malarial anemia","volume":"171","author":"Lindorfer","year":"2016","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2020.108450_bb0050","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1021\/acs.jmedchem.8b00560","article-title":"New Analogs of the complement C3 inhibitor compstatin with increased solubility and improved pharmacokinetic profile","volume":"61","author":"Berger","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.clim.2020.108450_bb0055","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41573-019-0031-6","article-title":"Clinical promise of next-generation complement therapeutics","volume":"18","author":"Mastellos","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.clim.2020.108450_bb0060","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.clim.2018.11.010","article-title":"Taming hemodialysis-induced inflammation: are complement C3 inhibitors a viable option?","volume":"198","author":"Mastellos","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2020.108450_bb0065","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1111\/jcmm.12667","article-title":"Complement inhibition decreases early fibrogenic events in the lung of septic baboons","volume":"19","author":"Silasi-Mansat","year":"2015","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.clim.2020.108450_bb0070","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/SHK.0000000000001127","article-title":"Protective effects of the complement inhibitor compstatin CP40 in hemorrhagic shock","volume":"51","author":"Van Griensven","year":"2019","journal-title":"Shock"},{"key":"10.1016\/j.clim.2020.108450_bb0075","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1097\/00003246-200009000-00004","article-title":"Phase I trial of the recombinant soluble complement receptor 1 in acute lung injury and acute respiratory distress syndrome","volume":"28","author":"Zimmerman","year":"2000","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.clim.2020.108450_bb0080","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.clim.2018.09.004","article-title":"Safety profile after prolonged C3 inhibition","volume":"197","author":"Reis","year":"2018","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2020.108450_bb0085","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3389\/fimmu.2019.00406","article-title":"Complement-dependent mechanisms and interventions in periodontal disease","volume":"10","author":"Hajishengallis","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2020.108450_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","author":"Magro","year":"2020","journal-title":"Transl. Res."},{"key":"10.1016\/j.clim.2020.108450_bb0095","article-title":"Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation","author":"Gao","year":"2020","journal-title":"MedRxiv"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661620303314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661620303314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:03:28Z","timestamp":1761494608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661620303314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":19,"alternative-id":["S1521661620303314"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2020.108450","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The first case of COVID-19 treated with the complement C3 inhibitor AMY-101","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2020.108450","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108450"}}